WearLinq eWave ECG patch usability in adults

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates the usability of the WearLinq eWave patch in a general adult population, including people with heart conditions and healthy adults. Participants will apply the patch for seven consecutive days, or longer if an endpoint is reached, and a subset will participate in an extended 30-day cohort. Data collection focuses on user interaction with the patch and the smartphone app, device tolerability, and any placement or skin-related issues. The study excludes individuals with implanted cardiac devices, MRI plans during the study, or skin conditions that could confound results. Lead sponsor is Wearlinq with ABio Clinical Research Partners as collaborator, conducted at ABio Clinical Research Partners in New London, NC.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult \>18 years old and able to consent
* Capable of using a smartphone app
* Willing to shave patch area if needed

Exclusion Criteria:

* Planning to undergo an MRI during the study period
* Known allergic reaction to adhesives or hydrogels or with family history of adhesive skin allergies, or any other dermatological conditional that could confound placement or results
* Presence of pacemaker, ICD or other implanted electronic devices
* Open wounds, lesions or infected or inflamed areas of skin at the placement site (left-center of chest/sternum)
* Pregnant or intending to become pregnant during the course of the study

Where it's running

• ABio Clinical Research Partners
  New London, North Carolina, United States Recruiting

Study contacts

• Study coordinator: Andrea Brown, MS
• Email: abrown@abioclinical.com
• Phone: 408-881-2611

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How age affects germinal center responses after flu and rabies vaccines

  Researchers will test how the immune system responds to flu and rabies vaccines in younger adults (18–40) and older adults (65+).

  Recruiting Phase 4 Washington University School of Medicine · St Louis, Missouri · NCT07914673

• Differentiating heart disease in autoimmune vs. type 2 diabetes

  This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.

  Recruiting University of Roma La Sapienza · Rome, Roma · NCT07911007

• Magnetic field maps with NV sensors for non-invasive heart measurements

  This study tests whether diamond-based NV magnetometers can non-invasively detect and map the heart's magnetic field in healthy adults.

  Recruiting Robert Bosch GmbH · Renningen · NCT07908173

• Methylation analyses using home-based self-sampling in women with and without gynecological disease

  This study tests whether self-collected urine and vaginal samples can reveal DNA methylation markers that distinguish people with gynecological (pre-)cancers from cancer-free controls.

  Recruiting Universiteit Antwerpen · Edegem, Antwerp · NCT07902388

• Omega-3 status in healthy adults: comparing different fish-oil and algae-oil products

  This study tests whether various fish-oil and algae-oil products can raise the Omega-3 Index in healthy adults who don’t eat much fatty fish.

  Recruiting Nordic Naturals · London, Ontario · NCT07900425

• A safe, carefully dosed test of TBD11 in healthy adults

  This phase 1 study tests TBD11 in healthy adults to see if it is safe and tolerable and to understand how it behaves in the body, including how it interacts with other medicines.

  Recruiting Phase 1 Gates Medical Research Institute · Bloemfontein · NCT07883226

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.